Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Sionna Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-57.72	-47.26	-40.24
Depreciation & Amortization	-1.6	-0.1	-0.28
Share-Based Compensation	-	2.26	1.69
Other Operating Activities	10.86	1.4	2.76
Operating Cash Flow	-48.46	-43.7	-36.07
Capital Expenditures	-0.12	-1.12	-1.87
Change in Investments	-	28.47	-27.39
Investing Cash Flow	-135.01	27.35	-29.26
Share Issuance / Repurchase	-	0.03	110.86
Financing Cash Flow	180.38	0.03	110.86
Net Cash Flow	-3.1	-16.32	45.52
Free Cash Flow	-48.58	-44.82	-37.94

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).